Unlabelled: It is important to measure the rate of haemolysis in patients with sickle cell disease (SCD) to identify aplastic crises and indirectly assess the rate of vaso-occlusion and sequestration. The aim of this study was to assess whether end-tidal carbon monoxide (ETCOc) levels in children with sickle cell disease (SCD) could be measured reproducibly, reflected haemolysis and whether they were elevated compared to those of similarly aged, ethnic matched children without SCD (controls). ETCOc levels were measured non-invasively in 87 SCD children (age range 2.3-17.6 years) and 26 age and ethnic origin matched healthy controls using an electro-chemical sensor. The within- and between- occasion reproducibilities were assessed in ten and 15 SCD children respectively. ETCOc levels of 15 SCD children undergoing regular transfusions were related to carboxyhaemoglobin, haemoglobin and bilirubin levels. The within and between occasions' mean intrasubject coefficients of reproducibility were 5% and 18% respectively. Positive correlations were found between the ETCOc and carboxyhaemoglobin ( P =0.007) and bilirubin ( P =0.02) levels, and a significant negative correlation between the ETCOc and haemoglobin ( P =0.0002) levels. The mean and SD ETCOc levels of the SCD children (4.9 ppm; SD 1.7 ppm) were significantly higher than that of the controls (mean 1.3 ppm; SD 0.4 ppm) (difference between means 3.60; 95% C.I. 2.93-4.28; P <0.0001).
Conclusion: These results suggest that measurement of end-tidal carbon monoxide levels is a reliable and useful method to monitor haemolysis in children with sickle cell disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00431-004-1605-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ABO hemolytic disease of the newborn: a need for clarity and consistency in diagnosis.
J Perinatol
February 2023
Professor Emeritus, Division of Newborn Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Article Synopsis
- The diagnosis of ABO hemolytic disease of the newborn (ABO HDN) is often misapplied to all cases of hyperbilirubinemia in ABO incompatible neonates, leading to confusion and imprecision.
- Research shows the importance of a positive direct antiglobulin test (DAT) for accurate diagnosis, while cases lacking a positive DAT should not assume ABO HDN.
- A clear definition that includes ABO incompatibility, significant hyperbilirubinemia, and a positive DAT is necessary, and negative DAT results should prompt further investigation for alternative causes.
An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns.
J Pediatr
November 2022
Department of Neonatology, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China; National Clinical Research Center for Child Health, Hangzhou, China.
Objective: To establish a reference nomogram for end-tidal CO corrected for ambient CO (ETCOc) levels in term and late-preterm Chinese newborns and then assess its efficacy to identify hemolytic hyperbilirubinemia.
Study Design: We conducted a prospective study by measuring concurrent ETCOc and total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) levels collected postnatally at 12, 24, 48, 72, 96, and 120 hours of age. ETCOc at the 25th, 50th, 75th, and 95th percentiles at each epoch were used to construct the reference nomogram.
Reference intervals for end-tidal carbon monoxide of preterm neonates.
J Perinatol
January 2022
Division of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT, USA.
Objectives: We constructed reference intervals for end-tidal carbon monoxide (ETCOc) levels of neonates 28 to 34 weeks gestation in order to assess hemolytic rate.
Study Design: This is a prospective four-NICU study in Bangkok, Thailand, and Utah, USA.
Results: Of 226 attempted measurements, 92% were successful.
Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.
Semin Perinatol
February 2021
Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, CA, USA.
The predominant cause of elevated total/plasma bilirubin (TB) levels is from an increase in bilirubin production primarily because of ongoing hemolysis. If undiagnosed or untreated, the risk for developing extreme neonatal hyperbilirubinemia and possibly bilirubin-induced neurological dysfunction (BIND) is increased. Since carbon monoxide (CO) and bilirubin are produced in equimolar amounts during the heme catabolic process, measurements of end-tidal CO levels, corrected for ambient CO (ETCOc) can be used as a direct indicator of ongoing hemolysis.
View Article and Find Full Text PDFNoninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.
Neonatology
August 2021
Department of Neonatology, KK Women's and Children's Hospital, Singapore, Singapore.
Background: Hemolytic hyperbilirubinemia due to blood group incompatibility or glucose-6-phosphate dehydrogenase deficiency (G6PD) is a common cause of significant hyperbilirubinemia. Hemolysis in a hyperbilirubinemic infant increases the risk of bilirubin neurotoxicity. A new portable device (CoSense) can rapidly detect breath end-tidal carbon monoxide corrected to ambient carbon monoxide (ETCOc).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!